PL380826A1 - Zastosowanie kompleksów Ginko w celu zwiększenia funkcji poznawczych i złagodzenia zmęczenia umysłowego - Google Patents
Zastosowanie kompleksów Ginko w celu zwiększenia funkcji poznawczych i złagodzenia zmęczenia umysłowegoInfo
- Publication number
- PL380826A1 PL380826A1 PL380826A PL38082605A PL380826A1 PL 380826 A1 PL380826 A1 PL 380826A1 PL 380826 A PL380826 A PL 380826A PL 38082605 A PL38082605 A PL 38082605A PL 380826 A1 PL380826 A1 PL 380826A1
- Authority
- PL
- Poland
- Prior art keywords
- cognitive function
- memory
- ginko
- compounds
- applying
- Prior art date
Links
- 230000003920 cognitive function Effects 0.000 title abstract 4
- 244000194101 Ginkgo biloba Species 0.000 title 1
- 210000004556 brain Anatomy 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 abstract 2
- 241000218628 Ginkgo Species 0.000 abstract 2
- 235000011201 Ginkgo Nutrition 0.000 abstract 2
- 235000008100 Ginkgo biloba Nutrition 0.000 abstract 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 abstract 2
- 208000019914 Mental Fatigue Diseases 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000036651 mood Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04001937A EP1559430B1 (en) | 2004-01-29 | 2004-01-29 | Use of ginkgo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL380826A1 true PL380826A1 (pl) | 2007-03-19 |
| PL219337B1 PL219337B1 (pl) | 2015-04-30 |
Family
ID=34639409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL380826A PL219337B1 (pl) | 2004-01-29 | 2005-01-26 | Zastosowanie lipofilowego kompleksu Ginkgo biloba z fosfolipidem do wytwarzania produktu leczniczego i nieterapeutyczne zastosowanie dodatku do żywności |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8591965B2 (pl) |
| EP (1) | EP1559430B1 (pl) |
| JP (1) | JP5300196B2 (pl) |
| KR (2) | KR101249667B1 (pl) |
| CN (1) | CN1913907B (pl) |
| AT (1) | ATE428312T1 (pl) |
| AU (1) | AU2005210091B2 (pl) |
| CA (1) | CA2554760C (pl) |
| DE (1) | DE602004020574D1 (pl) |
| DK (1) | DK1559430T3 (pl) |
| ES (1) | ES2323864T3 (pl) |
| HK (1) | HK1098380A1 (pl) |
| IL (1) | IL177118A (pl) |
| NO (1) | NO331190B1 (pl) |
| PL (1) | PL219337B1 (pl) |
| PT (1) | PT1559430E (pl) |
| RU (1) | RU2368385C2 (pl) |
| SG (1) | SG172727A1 (pl) |
| SI (1) | SI1559430T1 (pl) |
| WO (1) | WO2005074956A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100723609B1 (ko) * | 2006-04-28 | 2007-06-04 | 주식회사 유유 | 신규한 조성의 알츠하이머형 치매 및 파킨슨씨병 예방 또는 치료용 은행잎 추출물, 그리고 은행잎으로부터의 추출 및 정제 방법 |
| ES2709633T3 (es) * | 2007-12-21 | 2019-04-17 | Dr Willmar Schwabe Gmbh & Co Kg | Uso de un extracto de hojas de Ginkgo biloba |
| ITTO20080532A1 (it) * | 2008-07-10 | 2010-01-11 | Euro Pharma S R L | Integratore dietetico atto al potenziamento neuronale e sensoriale |
| IT1397386B1 (it) * | 2010-01-12 | 2013-01-10 | Indena Spa | Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso. |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
| CN103156022B (zh) * | 2011-12-09 | 2014-12-17 | 四川科伦药物研究有限公司 | 一种银杏叶保健茶及其制备方法 |
| SG11201703944XA (en) * | 2014-11-20 | 2017-06-29 | Enzymotec Ltd | Phospholipid preparations for the improvement of communication skills |
| JP6923940B2 (ja) | 2016-04-15 | 2021-08-25 | 慶裕 広川 | 認知機能改善剤 |
| CN105901649A (zh) * | 2016-05-03 | 2016-08-31 | 王胜 | 一种含银杏提取物的植物盐及其制备方法 |
| RU2680809C2 (ru) * | 2016-12-20 | 2019-02-27 | федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) | Способ получения наноразмерной фитосомальной системы |
| US20200226948A1 (en) * | 2019-01-14 | 2020-07-16 | Robert Warren | Time and Attention Evaluation System |
| KR20220123272A (ko) * | 2020-01-03 | 2022-09-06 | 바이오서치 에스.에이. | 인지 장애 치료용 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2929959A1 (de) * | 1979-07-24 | 1981-02-19 | Hoechst Ag | Thermoplastische kunststoffmasse |
| IT1201149B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
| IT1238684B (it) * | 1990-02-09 | 1993-09-01 | Indena Spa | Derivati del bilobalide,loro usi e formulazioni che li contegono |
| TR200400577T4 (tr) * | 1999-12-17 | 2004-04-21 | Pharmaton S.A. | Kognitif yetenekleri artırmak için ginseng ve ginkgo kombinasyonu. |
| US6733797B1 (en) * | 2000-11-15 | 2004-05-11 | William K. Summers | Neuroceutical for improving memory and cognitive abilities |
| KR20020069539A (ko) * | 2001-02-26 | 2002-09-05 | 주식회사 두산 | 뇌세포 보호용 조성물 |
| WO2003013549A2 (de) * | 2001-08-09 | 2003-02-20 | Degussa Food Ingredients Gmbh | Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern |
| JP2003169632A (ja) * | 2001-12-08 | 2003-06-17 | Sapuri:Kk | 米胚芽油、卵黄油及びホスファチジルセリン含有の健康食品 |
| JP2003261456A (ja) * | 2002-03-08 | 2003-09-16 | Howaizu:Kk | 脳の老化予防剤 |
| US6572899B1 (en) * | 2002-07-03 | 2003-06-03 | Vitacost.Com, Inc. | Memory loss treatment formulation |
-
2004
- 2004-01-29 EP EP04001937A patent/EP1559430B1/en not_active Expired - Lifetime
- 2004-01-29 DE DE602004020574T patent/DE602004020574D1/de not_active Expired - Lifetime
- 2004-01-29 SI SI200431142T patent/SI1559430T1/sl unknown
- 2004-01-29 AT AT04001937T patent/ATE428312T1/de active
- 2004-01-29 ES ES04001937T patent/ES2323864T3/es not_active Expired - Lifetime
- 2004-01-29 PT PT04001937T patent/PT1559430E/pt unknown
- 2004-01-29 DK DK04001937T patent/DK1559430T3/da active
-
2005
- 2005-01-26 PL PL380826A patent/PL219337B1/pl unknown
- 2005-01-26 RU RU2006127272/15A patent/RU2368385C2/ru active
- 2005-01-26 CN CN2005800033273A patent/CN1913907B/zh active Active
- 2005-01-26 JP JP2006550086A patent/JP5300196B2/ja active Active
- 2005-01-26 KR KR1020117024637A patent/KR101249667B1/ko active IP Right Grant
- 2005-01-26 CA CA2554760A patent/CA2554760C/en active Active
- 2005-01-26 US US10/587,468 patent/US8591965B2/en active Active
- 2005-01-26 WO PCT/EP2005/000738 patent/WO2005074956A1/en active Application Filing
- 2005-01-26 KR KR1020067015129A patent/KR101249633B1/ko active IP Right Grant
- 2005-01-26 SG SG2011046141A patent/SG172727A1/en unknown
- 2005-01-26 AU AU2005210091A patent/AU2005210091B2/en active Active
-
2006
- 2006-07-27 NO NO20063463A patent/NO331190B1/no unknown
- 2006-07-27 IL IL177118A patent/IL177118A/en active IP Right Grant
-
2007
- 2007-05-10 HK HK07104973.6A patent/HK1098380A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1559430E (pt) | 2009-06-16 |
| ATE428312T1 (de) | 2009-05-15 |
| WO2005074956A1 (en) | 2005-08-18 |
| SI1559430T1 (sl) | 2009-08-31 |
| KR20060130148A (ko) | 2006-12-18 |
| IL177118A (en) | 2011-03-31 |
| RU2368385C2 (ru) | 2009-09-27 |
| ES2323864T3 (es) | 2009-07-27 |
| RU2006127272A (ru) | 2008-02-10 |
| AU2005210091A1 (en) | 2005-08-18 |
| DE602004020574D1 (de) | 2009-05-28 |
| CA2554760A1 (en) | 2005-08-18 |
| US8591965B2 (en) | 2013-11-26 |
| DK1559430T3 (da) | 2009-07-20 |
| JP2007519668A (ja) | 2007-07-19 |
| CN1913907B (zh) | 2011-03-30 |
| EP1559430B1 (en) | 2009-04-15 |
| CA2554760C (en) | 2018-10-09 |
| AU2005210091B2 (en) | 2010-06-03 |
| IL177118A0 (en) | 2008-03-20 |
| HK1098380A1 (en) | 2007-07-20 |
| JP5300196B2 (ja) | 2013-09-25 |
| KR101249633B1 (ko) | 2013-04-02 |
| PL219337B1 (pl) | 2015-04-30 |
| KR20110123289A (ko) | 2011-11-14 |
| NO331190B1 (no) | 2011-10-31 |
| SG172727A1 (en) | 2011-07-28 |
| US20080226757A1 (en) | 2008-09-18 |
| KR101249667B1 (ko) | 2013-04-02 |
| NO20063463L (no) | 2006-07-27 |
| CN1913907A (zh) | 2007-02-14 |
| EP1559430A1 (en) | 2005-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL380826A1 (pl) | Zastosowanie kompleksów Ginko w celu zwiększenia funkcji poznawczych i złagodzenia zmęczenia umysłowego | |
| Stoodley et al. | The cerebellum and dyslexia. | |
| Waites | Trauma and survival: Post-traumatic and dissociative disorders in women. | |
| BRPI0416799A (pt) | sistema de orientação de sono e métodos relacionados | |
| HK1065480A1 (en) | Preparation for improving the action of receptors | |
| PT2527315E (pt) | Compostos, composições e métodos para o tratamento de doenças da amiloide e sinucleínopatias tais como doença de alzheimer, diabetes do tipo 2, e doença de parkinson | |
| IL177787A0 (en) | 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease | |
| HK1087398A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
| EP1817050A4 (en) | DIAGNOSIS AND TREATMENT OF MORBUS ALZHEIMER | |
| WO2004077938A3 (en) | Novel chemical entities and methods for their use in treatment of metabolic disorders | |
| HK1091657A1 (en) | Use of pyrazolopyridines for the treatment of cognitive deficits | |
| DE60009145D1 (de) | Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen | |
| Toman | Body mass index and its impact on the therapeutic alliance in the work with eating disorder patients | |
| DE60228988D1 (de) | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen | |
| ATE325616T1 (de) | Zusammensetzungen zur behandlung von angstzuständen und damit verbundenen erkrankungen | |
| WO2007048034A3 (en) | Use of androgens for the treatment of parkinson' s disease | |
| Rishel | Child outcomes in community mental health: Effects of maternal mental health status | |
| Hwang et al. | Effects of Bibliotherapy of Dotard Dementias Old Adults | |
| Nassif | Investigating creativity with the MMPI-2: A preliminary creativity scale | |
| Rondanelli et al. | Mild cognitive impairment in elderly and supplementation | |
| Rao et al. | Sakshin (witness): A directive principle for psychotherapy. | |
| FI20065414A0 (fi) | Maitopohjaisia elintarvikkeita, jotka sisältävät keskushermoston lipidejä | |
| Hook-Costigan | Eye preferences of marmosets for viewing novel stimuli and their relation to hand, foot and facial expression asymmetries. | |
| Kawanobe | Affective mapping between music and color combination | |
| Mero | Asperger Syndrome With Emotional Disorder—Treatment With Psychoanalytic Psychotherapy |